Clinical Trials · NCT06639464
Semaglutide for Helping Opioid Recovery
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Brigham and Women's Hospital
- Enrollment
- 46
- Start date
- Jun 2025
- Locations
- 1 site, United States
- Primary endpoint
- Cue-induced Cravings for Opioids